Considering that overexpression of Mettl3 can aggravate liver metabolic disorders and hepatogenous diabetes induced by HFD, we supposed that Mettl3 ablation in liver could resist HFD-induced metabolic syndrome. Here, METTL3 is linked to metabolic syndrome.